Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
0.3269
Dollar change
-0.0081
Percentage change
-2.42
%
Index- P/E- EPS (ttm)-11.23 Insider Own0.01% Shs Outstand80.82M Perf Week-8.71%
Market Cap26.42M Forward P/E- EPS next Y-2.60 Insider Trans0.00% Shs Float80.81M Perf Month-11.17%
Income-123.42M PEG- EPS next Q-1.55 Inst Own20.77% Short Float1.20% Perf Quarter-20.25%
Sales3.99M P/S6.62 EPS this Y63.79% Inst Trans25.59% Short Ratio0.66 Perf Half Y-58.62%
Book/sh6.80 P/B0.05 EPS next Y64.93% ROA-63.37% Short Interest0.97M Perf Year-90.66%
Cash/sh0.09 P/C3.82 EPS next 5Y- ROE-69.20% 52W Range0.26 - 4.00 Perf YTD-18.88%
Dividend Est.- P/FCF- EPS past 5Y79.97% ROI-101.54% 52W High-91.83% Beta2.27
Dividend TTM- Quick Ratio1.02 Sales past 5Y0.00% Gross Margin-49.94% 52W Low25.73% ATR (14)0.03
Dividend Ex-Date- Current Ratio1.77 EPS Y/Y TTM68.08% Oper. Margin-3103.01% RSI (14)43.49 Volatility9.23% 8.01%
Employees117 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin-3094.01% Recom1.00 Target Price5.12
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q57.74% Payout- Rel Volume1.06 Prev Close0.34
Sales Surprise-31.22% EPS Surprise-22.82% Sales Q/Q- EarningsNov 09 AMC Avg Volume1.46M Price0.33
SMA20-7.25% SMA50-3.30% SMA200-56.07% Trades Volume1,565,916 Change-2.42%
Date Action Analyst Rating Change Price Target Change
Apr-18-22Initiated Noble Capital Markets Outperform
Apr-18-19Upgrade ROTH Capital Neutral → Buy $4
Aug-18-17Upgrade ROTH Capital Neutral → Buy $6
Sep-07-16Downgrade ROTH Capital Buy → Neutral
Feb-17-16Reiterated Oppenheimer Outperform $18 → $10
Nov-04-15Initiated Cantor Fitzgerald Buy
Jun-12-15Initiated Oppenheimer Outperform $18
Feb-17-15Reiterated ROTH Capital Buy $10 → $12
Sep-29-14Reiterated ROTH Capital Buy $17 → $10
Mar-25-24 08:00AM
Mar-21-24 08:00AM
Mar-20-24 08:00AM
Mar-19-24 08:00AM
Mar-12-24 08:00AM
08:00AM Loading…
Mar-11-24 08:00AM
Mar-07-24 09:37AM
08:00AM
Mar-06-24 08:00AM
Mar-05-24 08:00AM
Feb-29-24 08:00AM
Feb-28-24 08:00AM
06:56AM
06:54AM
Feb-27-24 08:00AM
08:00AM Loading…
Feb-26-24 08:00AM
Feb-25-24 02:12PM
Feb-23-24 09:30AM
Feb-20-24 08:00AM
Feb-16-24 09:30AM
Feb-15-24 08:45AM
08:00AM
Feb-14-24 08:00AM
Feb-13-24 08:00AM
Feb-12-24 08:00AM
Feb-01-24 08:00AM
Jan-31-24 07:00AM
Jan-30-24 05:00PM
Jan-29-24 07:00AM
Jan-26-24 05:31PM
07:00AM Loading…
Jan-25-24 07:00AM
Jan-24-24 03:28PM
Jan-09-24 07:00AM
Jan-03-24 07:00AM
Jan-02-24 06:08AM
Dec-20-23 10:35AM
10:30AM
Dec-14-23 09:15AM
Dec-12-23 01:40PM
Dec-11-23 07:00AM
Dec-04-23 07:00AM
Nov-28-23 07:00AM
Nov-20-23 01:57PM
01:53PM
Nov-15-23 07:00AM
Nov-13-23 07:00AM
Nov-09-23 04:15PM
Nov-02-23 08:00AM
Oct-31-23 05:00PM
Oct-30-23 07:00AM
Oct-26-23 07:00AM
Oct-25-23 08:45AM
Oct-19-23 07:00AM
Oct-18-23 07:00AM
Oct-16-23 07:00AM
Oct-12-23 07:00AM
Oct-11-23 07:00AM
Oct-09-23 07:00AM
Oct-04-23 07:00AM
Sep-28-23 09:00PM
04:01PM
Sep-27-23 08:30AM
Sep-26-23 10:18AM
Sep-21-23 07:00AM
Sep-19-23 01:54PM
Sep-18-23 07:00AM
Sep-15-23 09:30AM
Sep-14-23 07:00AM
Sep-06-23 07:00AM
Sep-05-23 07:32AM
07:05AM
07:00AM
Aug-28-23 01:13PM
Aug-21-23 01:18PM
07:00AM
Aug-17-23 07:00AM
Aug-16-23 07:00AM
Aug-10-23 04:30PM
Aug-07-23 07:00AM
Aug-01-23 04:01PM
07:00AM
Jul-31-23 07:00AM
Jul-27-23 09:31PM
04:01PM
Jul-26-23 04:05PM
Jul-24-23 07:00AM
Jul-17-23 07:00AM
Jul-10-23 07:00AM
Jul-06-23 08:09AM
07:00AM
Jul-03-23 07:00AM
Jun-28-23 03:21PM
Jun-26-23 07:00AM
Jun-21-23 08:25AM
Jun-15-23 07:00AM
Jun-07-23 07:00AM
Jun-05-23 07:00AM
May-31-23 01:24PM
07:00AM
May-30-23 07:00AM
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.